To better understand the global civil sector on a wide range of healthcare issues in interviews on behalf of Pfizer with 350 healthcare opinion leaders from China, Great Britain, Japan, Mexico, South Africa and the US with representatives from government, health policy, NGOs and multilateral organizations as shown below.